Source: Annual Congress 2004 - Improvements in delivery of inhaled agents
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. M. Coldham, T. Davies, S. Mulrennan, J. Seymour, G. Wright, A. Morice (Hull, United Kingdom). The assesment of aerosol solution lung deposition in cystic fibrosis patients. Eur Respir J 2004; 24: Suppl. 48, 3588

Member's Comments

No comment yet.

Related content which might interest you: Changes in lung gas mixing after physiotherapy in adults with cystic fibrosis Source: Annual Congress 2007 - Critical care and airways clearance Year: 2007 Long-term clearance from small airways in patients with cystic fibrosis Source: Eur Respir J 2005; 25: 317-323 Year: 2005 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Control of the inhalation technique in cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 262s Year: 2006 Lung clearance index and lung ultrasound in cystic fibrosis children Source: International Congress 2018 – Cystic fibrosis: diagnosis and monitoring Year: 2018 Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis Source: Eur Respir J 2003 Dec 01;22(6):972-979 Year: 2003 Relationship between airflow limitation and lung volume in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 301s Year: 2002 Functional respiratory imaging assessment of the aerosol deposition of inhaled levofloxacin in cystic fibrosis lungs Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021 Inhalation therapy in cystic fibrosis Source: School Course 2013 - Cystic Fibrosis Year: 2013 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Pleural pathology and lung fibrosis in patients with retroperitoneal fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 146s Year: 2004 Deposition of aerosols in the lung periphery of patients with lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 212s Year: 2001 Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020 Year: 2021 Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations Source: Eur Respir J 2015; 46: 1055-1064 Year: 2015 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 Long-term course of lung clearance index among patients with cystic fibrosis Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment Year: 2020 Single-breath washout and association with structural lung changes in children with cystic fibrosis Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016